Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of mosapride citrate injection for postoperative gastrointestinal dysfunction
CTR20242912Phase 2Completed
- Sponsor
- Shandong New Era Pharmaceutical
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Postoperative gastrointestinal dysfunction (POGD) comparing Mosapride citrate injection with Placebo (0.9% sodium chloride injection) (2 arms). Started Aug 2024; status: completed.
02
Drugs
mosapride
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on CTR20242912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242912.